Literature DB >> 11085988

Functional interaction of human Cdc37 with the androgen receptor but not with the glucocorticoid receptor.

J Rao1, P Lee, S Benzeno, C Cardozo, J Albertus, D M Robins, A J Caplan.   

Abstract

Cdc37 is a molecular chaperone closely associated with the folding of protein kinases. Results from studies using a yeast model system showed that it was also important for activation of the human androgen receptor (AR). Based on results from the yeast model system (Fliss, A. E., Fang, Y., Boschelli, F., and Caplan, A. J. (1997) Mol. Biol. Cell 8, 2501-2509), we initiated studies to address whether AR and Cdc37 interact with each other in animal cell systems. Our results show that Cdc37 binds to AR but not to glucocorticoid receptors (GR) synthesized in rabbit reticulocyte lysates. This binding occurs via the ligand-binding domain of the AR in a manner that is partially dependent on Hsp90 and the presence of hormone. Further studies using the yeast system showed that Cdc37 is not interchangeable with Hsp90, suggesting that it functions at a distinct step in the activation pathway. Expression of a dominant negative form of Cdc37 in animal cells down-regulates full-length AR but has very little effect on an AR truncation lacking the ligand-binding domain or full-length GR. These results reveal differences in the mechanisms by which AR and GR become active transcription factors and strengthen the notion that Cdc37 has a wider range of polypeptide clients than was realized previously.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085988     DOI: 10.1074/jbc.M007385200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Hsp90 reaches new heights. Conference on the Hsp90 chaperone machine.

Authors:  Avrom J Caplan; Sophie Jackson; David Smith
Journal:  EMBO Rep       Date:  2003-02       Impact factor: 8.807

Review 2.  Cdc37 goes beyond Hsp90 and kinases.

Authors:  Morag MacLean; Didier Picard
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

3.  CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37.

Authors:  Yoshihiko Miyata; Eisuke Nishida
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

4.  Cdc37p is required for stress-induced high-osmolarity glycerol and protein kinase C mitogen-activated protein kinase pathway functionality by interaction with Hog1p and Slt2p (Mpk1p).

Authors:  Patricija Hawle; Danielle Horst; Jan Paul Bebelman; Xiao Xian Yang; Marco Siderius; Saskia M van der Vies
Journal:  Eukaryot Cell       Date:  2007-01-12

5.  Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer.

Authors:  Barbara Comuzzi; Marianne D Sadar
Journal:  Cellscience       Date:  2006-07-27

6.  Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis.

Authors:  Chaitanya A Patwardhan; Abdul Fauq; Laura B Peterson; Charles Miller; Brian S J Blagg; Ahmed Chadli
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

7.  Cdc37 engages in stable, S14A mutation-reinforced association with the most atypical member of the yeast kinome, Cdk-activating kinase (Cak1).

Authors:  Stefan Millson; Patricija van Oosten-Hawle; Mohammed A Alkuriji; Andrew Truman; Marco Siderius; Peter W Piper
Journal:  Cell Stress Chaperones       Date:  2014-01-23       Impact factor: 3.667

Review 8.  Cdc37 as a co-chaperone to Hsp90.

Authors:  Stuart K Calderwood
Journal:  Subcell Biochem       Date:  2015

9.  Fission yeast Cdc37 is required for multiple cell cycle functions.

Authors:  P K Westwood; I V Martin; P A Fantes
Journal:  Mol Genet Genomics       Date:  2003-12-03       Impact factor: 3.291

10.  Novel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growth.

Authors:  Fayi Wu; Stephanie O Peacock; Shuyun Rao; Sandra K Lemmon; Kerry L Burnstein
Journal:  J Biol Chem       Date:  2012-12-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.